Nisa Investment Advisors, LLC Sorrento Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$0.17 - $1.19 $34 - $238	-200 Reduced 6.48%	2,886 $1,000
Q4 2022 Feb 02, 2023	SELL	$0.74 - $1.83 $8,066 - $19,947	-10,900 Reduced 77.94%	3,086 $3,000
Q2 2022 Aug 03, 2022	SELL	$1.24 - $2.33 $126,856 - $238,368	-102,304 Reduced 87.97%	13,986 $28,000
Q1 2022 Apr 29, 2022	BUY	$2.0 - $4.9 $226,180 - $554,141	113,090 Added 3534.06%	116,290 $271,000
Q4 2021 Feb 03, 2022	SELL	$4.65 - $7.23 $1.19 Million - $1.85 Million	-255,250 Reduced 98.76%	3,200 $11,000
Q2 2021 Aug 06, 2021	BUY	$6.35 - $10.0 $1.59 Million - $2.5 Million	250,000 Added 2958.58%	258,450 $2.5 Million
Q1 2021 Apr 26, 2021	SELL	$7.03 - $16.51 $5,272 - $12,382	-750 Reduced 8.15%	8,450 $70,000
Q4 2020 Jan 25, 2021	SELL	$5.76 - $11.95 $50,976 - $105,757	-8,850 Reduced 49.03%	9,200 $63,000
Q3 2020 Oct 20, 2020	BUY	$6.17 - $18.82 $100,879 - $307,707	16,350 Added 961.76%	18,050 $201,000
Q2 2020 Jul 27, 2020	SELL	$1.73 - $6.76 $242 - $946	-140 Reduced 7.61%	1,700 $11,000
Q1 2020 Apr 17, 2020	BUY	$1.57 - $4.76 $2,888 - $8,758	1,840 New	1,840 $3,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.